123 related articles for article (PubMed ID: 30657372)
1. Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation?
Hong JC; Foote J; Broadwater G; Sosa JA; Gaillard S; Havrilesky LJ; Chino JP
JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657372
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer.
Shaverdian N; Gondi V; Sklenar KL; Dunn EF; Petereit DG; Straub MR; Bradley KA
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):562-8. PubMed ID: 23561652
[TBL] [Abstract][Full Text] [Related]
3. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
[TBL] [Abstract][Full Text] [Related]
4. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy.
Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
Brachytherapy; 2016; 15(6):845-850. PubMed ID: 27720204
[TBL] [Abstract][Full Text] [Related]
7. Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
Graves S; Seagle BL; Strohl AE; Shahabi S; Nieves-Neira W
Int J Gynecol Cancer; 2017 Feb; 27(2):390-395. PubMed ID: 27984375
[TBL] [Abstract][Full Text] [Related]
8. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
[TBL] [Abstract][Full Text] [Related]
9. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
10. Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.
Brower JV; Chen S; Bassetti MF; Yu M; Harari PM; Ritter MA; Baschnagel AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):985-993. PubMed ID: 27869098
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome.
Jhawar S; Hathout L; Elshaikh MA; Beriwal S; Small W; Mahmoud O
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1132-1141. PubMed ID: 28721897
[TBL] [Abstract][Full Text] [Related]
12. Impact of age on receipt of curative treatment for cervical cancer: an analysis of patterns of care and survival in a large, national cohort.
Albert A; Lee A; Allbright R; Vijayakumar S
J Geriatr Oncol; 2019 May; 10(3):465-474. PubMed ID: 30361099
[TBL] [Abstract][Full Text] [Related]
13. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
Seagle BL; Kanis M; Strohl AE; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
[TBL] [Abstract][Full Text] [Related]
14. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
[TBL] [Abstract][Full Text] [Related]
16. Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis.
Tergas AI; Neugut AI; Chen L; Burke WM; Hershman DL; Wright JD
Cancer Invest; 2016; 34(3):137-47. PubMed ID: 26986809
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
Nugent EK; Case AS; Hoff JT; Zighelboim I; DeWitt LL; Trinkhaus K; Mutch DG; Thaker PH; Massad LS; Rader JS
Gynecol Oncol; 2010 Mar; 116(3):438-41. PubMed ID: 19896180
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
Haque W; Verma V; Butler EB; Teh BS
Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
[TBL] [Abstract][Full Text] [Related]
19. Triple-modality treatment in patients with advanced stage tonsil cancer.
Roden DF; Schreiber D; Givi B
Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
[TBL] [Abstract][Full Text] [Related]
20. The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy.
Song S; Rudra S; Hasselle MD; Dorn PL; Mell LK; Mundt AJ; Yamada SD; Lee NK; Hasan Y
Cancer; 2013 Jan; 119(2):325-31. PubMed ID: 22806897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]